BROWNSTEIN HYATT FARBER SCHRECK, LLP for ABBVIE
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 18, 2025 | $80,000 | Replaced |
| 1st Quarter - Amendment | Apr 18, 2025 | $80,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to patient access, pharmaceutical manufacturing, Patent reform and drug pricing both domestic and international Issues related to Medicare drug pricing and reimbursement HELP Copays Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
| ELIZABETH ANNE MAIER | — |
| LAUREN ALEXANDRA MISH | — |
| ALFRED MOTTUR | — |
| ZACHARY PFISTER | — |
| ADAM STEINMETZ | — |
| DEEMA TARAZI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.